United States · FDA National Drug Code directory

Trandolapril and Verapamil Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68462-329_770b4914-a475-4841-83f8-79261f115eff
Product NDC: 68462-329
Form: TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term: Trandolapril and Verapamil Hydrochloride
Labeler: Glenmark Pharmaceuticals Inc., USA
Marketing category: ANDA
Marketing start / end (source format): 20150225
Source listing expiry: 20271231

Source-listed ingredients

TRANDOLAPRIL — 4 mg/1
VERAPAMIL HYDROCHLORIDE — 240 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-01) · 68462-329-01
1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-10) · 68462-329-10

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →